The epidemiology of multiple sclerosis (MS) is well studied owing to its prevalence and position as the main cause of non-traumatic disability among young adults. The usual age of onset for ...

Multiple sclerosis is a long-term autoimmune disorder in which the immune system mistakenly attacks the protective sheath ...

[T]he epidemiology of multiple sclerosis is quite unique because there is a very striking geographical distribution. Professor Alberto Ascherio Researchers had known that there was something odd ...

Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Bristol-Myers Squibb, TG Therapeutics, Hoffmann-La Roche, Atara Biotherapeutics ...

MS prevalence has increased by about one-third in New Zealand in recent decades, though some barriers to diagnosis still ...

Researchers from the University of California San Diego School of Medicine have discovered that children living with multiple ...

Lead author Dr Natalia Boven, a postdoctoral fellow from the University’s COMPASS Research Centre, says the study found the ...

A University of Auckland study reveals the number of people diagnosed with the chronic condition lifted by a third between 2006 and 2022. Study author Natalia Boven says while European New Zealanders ...

However, finding the connection was not easy. “It started with the observation that the epidemiology of multiple sclerosis is quite unique because there is a very striking geographical ...